Stockscreener 앱 받기
104.24
0.66%
-0.69
시간 외 거래:
104.24
전일 마감가:
$104.93
열려 있는:
$104.54
하루 거래량:
4.82M
Relative Volume:
0.59
시가총액:
$151.13B
수익:
$17.55B
순이익/손실:
$2.03B
주가수익비율:
76.09
EPS:
1.37
순현금흐름:
$2.72B
1주 성능:
+2.02%
1개월 성능:
+16.21%
6개월 성능:
+21.86%
1년 성능:
+43.09%
1일 변동 폭
$103.54
$104.81
1주일 범위
$101.46
$105.54
52주 변동 폭
$71.88
$107.17
보스턴사이언티픽 Stock (BSX) Company Profile
명칭
Boston Scientific Corp
전화
508-683-4000
주소
300 BOSTON SCIENTIFIC WAY, MARLBOROUGH, MA
BSX을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
BSX
Boston Scientific Corp
|
104.24 | 151.13B | 17.55B | 2.03B | 2.72B | 1.37 |
|
ABT
Abbott Laboratories
|
132.60 | 224.65B | 42.34B | 13.50B | 6.66B | 7.71 |
|
SYK
Stryker Corp
|
381.36 | 139.34B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
83.45 | 107.01B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
75.11 | 44.25B | 5.54B | 4.18B | 259.90M | 7.00 |
보스턴사이언티픽 Stock (BSX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-04-16 | 업그레이드 | Needham | Hold → Buy |
| 2025-01-10 | 업그레이드 | Deutsche Bank | Hold → Buy |
| 2024-10-18 | 다운그레이드 | Needham | Buy → Hold |
| 2024-05-30 | 개시 | Goldman | Buy |
| 2024-02-01 | 업그레이드 | Mizuho | Neutral → Buy |
| 2023-07-19 | 개시 | Robert W. Baird | Outperform |
| 2023-06-30 | 개시 | CL King | Buy |
| 2023-05-30 | 재개 | Morgan Stanley | Overweight |
| 2023-03-29 | 개시 | UBS | Buy |
| 2022-12-22 | 개시 | Mizuho | Neutral |
| 2022-12-20 | 재개 | Citigroup | Buy |
| 2022-10-18 | 개시 | Barclays | Overweight |
| 2022-10-12 | 개시 | Jefferies | Buy |
| 2022-07-06 | 개시 | Wolfe Research | Outperform |
| 2022-05-27 | 업그레이드 | Needham | Hold → Buy |
| 2022-04-13 | 재개 | Truist | Buy |
| 2022-03-02 | 재개 | BofA Securities | Buy |
| 2021-12-10 | 개시 | RBC Capital Mkts | Outperform |
| 2021-05-26 | 다운그레이드 | Needham | Buy → Hold |
| 2021-05-25 | 개시 | Barclays | Overweight |
| 2021-04-15 | 개시 | Atlantic Equities | Overweight |
| 2020-09-17 | 개시 | Truist | Buy |
| 2020-09-11 | 개시 | Wolfe Research | Peer Perform |
| 2020-04-22 | 다운그레이드 | SVB Leerink | Outperform → Mkt Perform |
| 2020-04-01 | 업그레이드 | Goldman | Neutral → Buy |
| 2020-03-05 | 개시 | Citigroup | Buy |
| 2020-02-13 | 개시 | Goldman | Neutral |
| 2020-02-06 | 재개 | BTIG Research | Buy |
| 2019-12-30 | 재확인 | Cowen | Outperform |
| 2019-12-19 | 다운그레이드 | Needham | Strong Buy → Buy |
| 2019-09-05 | 재개 | JP Morgan | Overweight |
| 2019-09-03 | 재개 | Barclays | Overweight |
| 2019-05-13 | 업그레이드 | Evercore ISI | In-line → Outperform |
| 2018-11-28 | 개시 | UBS | Buy |
| 2018-10-16 | 개시 | Barclays | Overweight |
| 2018-10-02 | 재확인 | Morgan Stanley | Overweight |
| 2018-09-07 | 재확인 | Needham | Strong Buy |
| 2018-09-04 | 업그레이드 | Jefferies | Hold → Buy |
| 2018-07-06 | 재확인 | Needham | Strong Buy |
| 2018-06-27 | 개시 | Bernstein | Outperform |
| 2018-04-26 | 재확인 | Needham | Strong Buy |
모두보기
보스턴사이언티픽 주식(BSX)의 최신 뉴스
Are Wall Street Analysts Predicting Boston Scientific Stock Will Climb or Sink? - Nasdaq
Are Wall Street Analysts Predicting Boston Scientific Stock Will Climb Or Sink? - Barchart.com
Boston Scientific Chief Financial Officer (CFO) Dan Brennan to retire; Jon Monson, senior vice president, Investor Relations to succeed Brennan - ADVFN
Boston Scientific, FDA Sued Over 'Unsafe' Spinal Implant - Law360
A Changing of the Guard at Boston Scientific, Wright Medical Group and Vision-Sciences - Medical Product Outsourcing
Can Boston Scientific Corporation (NYSE:BSX) Performance Keep Up Given Its Mixed Bag Of Fundamentals? - Yahoo Finance
Beyond the Balance Sheet: What SWOT Reveals About Boston Scienti - GuruFocus
$100 Invested In Boston Scientific 15 Years Ago Would Be Worth This Much Today - Benzinga
June 13th Options Now Available For Boston Scientific (BSX) - Nasdaq
BOSTON SCIENTIFIC CORP SEC 10-Q Report - TradingView
Here are the highest-paid Mass. life sciences CEOs - The Business Journals
Edwards Lifesciences Corporation (EW): Jim Cramer Says It’s a Hold — But Is Boston Scientific Now His Favorite? - Insider Monkey
Zacks Investment Ideas Feature Highlights: Boston Scientific, Meta Platforms And Microsoft - Barchart.com
Boston Scientific Announces Results for Second Quarter 2024 - Quantisnow
Indexes Take A Well-Deserved Pause; SAP, Boston Scientific, Credicorp In Focus - Investor's Business Daily
EMEA Growth & Product Launches to Support Boston Scientific Stock - MSN
The Zacks Analyst Blog Highlights Abbott Laboratories, Boston Scientific And Medtronic - Barchart.com
The Zacks Analyst Blog Highlights Walmart, Toyota Motor, Boston Scientific and Autoscope - Yahoo Finance
Boston Scientific has positive ICD, Watchman FLX, AI data - MassDevice
Top Stock Reports for Walmart, Toyota Motor & Boston Scientific - MSN
Here is Why Growth Investors Should Buy Boston Scientific (BSX) Now - Yahoo Finance
Boston Scientific CFO Dan Brennan to retire after nearly 30 years with the company - MedTech Dive
Boston Scientific reports outcomes from Farapulse and Farapoint trial - Yahoo Finance
Boston Scientific (BSX) Price Target Raised by Barclays Followin - GuruFocus
Boston Sci expects $200M tariff hit, still raises guidance - BioWorld MedTech
Boston Scientific has positive Farapulse, Farapoint data - MassDevice
Boston Scientific (BSX) Reports Positive Results for FARAPULSE S - GuruFocus
Boston Scientific (BSX) Reports Positive Results for FARAPULSE System in Atrial Fibrillation Study | BSX Stock News - GuruFocus
Second phase of ADVANTAGE AF study of FARAPULSE™ Pulsed Field Ablation System meets primary safety and efficacy endpoints – Company AnnouncementFT.com - Financial Times
Boston Scientific (NYSE:BSX) Announces CFO Retirement And Strong Earnings Growth - Yahoo Finance
Boston Scientific Analysts Boost Their Forecasts Following Upbeat Results - Benzinga
Global Neuroprosthetics Market Expanding Rapidly at a CAGR of ~13% by 2032 Amid Surge in Demand for Advanced Neurological Treatments | DelveInsight - GlobeNewswire Inc.
Boston Scientific (BSX) Price Target Raised to $117 by Truist An - GuruFocus
RBC Capital lifts Boston Scientific stock target to $120 - Investing.com
Why Boston Scientific (BSX) is a Top Growth Stock for the Long-Term - Nasdaq
Boston Scientific (BSX) Price Target Raised by Baird Amid Strong Q1 Performance | BSX Stock News - GuruFocus
Boston Scientific (BSX) Target Price Boosted by RBC Capital Afte - GuruFocus
Canaccord maintains Buy rating on Boston Scientific stock - Investing.com
Raymond James Adjusts Boston Scientific (BSX) Price Target, Reaffirms Strong Buy | BSX Stock News - GuruFocus
Boston Scientific Corporation (NYSE:BSX) Q1 2025 Earnings Call Transcript - Insider Monkey
Canaccord maintains Buy rating on Boston Scientific stock By Investing.com - Investing.com UK
Boston Scientific Stock (BSX): Solid Q1 Earnings Growth - Value The Markets
Petri Dish: Boston Scientific CFO retires; Biotech undergoes 1-for-20 reverse stock split - The Business Journals
Boston Scientific Corp (BSX) Q1 2025 Earnings Call Highlights: Strong Growth and Upgraded ... - Yahoo Finance
Boston Scientific Reports Strong Q1 2025 Growth - TipRanks
Boston Scientific: Q1 Earnings Snapshot - CT Insider
Boston Scientific Reports Strong Earnings Amid Challenges - TipRanks
Data backs Boston Scientific drug-eluting stent - MassDevice
BTIG Raises Price Target for Boston Scientific (BSX) to $124 Ami - GuruFocus
BTIG Raises Price Target for Boston Scientific (BSX) to $124 Amid Strong Outlook | BSX Stock News - GuruFocus
Why Boston Scientific (BSX) Stock Is Up Today - Yahoo Finance
보스턴사이언티픽 (BSX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.83%
1.65%
자본화:
|
볼륨(24시간):